Cross-Species Analyses Identify Dlgap2 as a Regulator of Age-Related Cognitive Decline and Alzheimer's Dementia

Cell Rep. 2020 Sep 1;32(9):108091. doi: 10.1016/j.celrep.2020.108091.

Abstract

Genetic mechanisms underlying age-related cognitive decline and dementia remain poorly understood. Here, we take advantage of the Diversity Outbred mouse population to utilize quantitative trait loci mapping and identify Dlgap2 as a positional candidate responsible for modifying working memory decline. To evaluate the translational relevance of this finding, we utilize longitudinal cognitive measures from human patients, RNA expression from post-mortem brain tissue, data from a genome-wide association study (GWAS) of Alzheimer's dementia (AD), and GWAS results in African Americans. We find an association between Dlgap2 and AD phenotypes at the variant, gene and protein expression, and methylation levels. Lower cortical DLGAP2 expression is observed in AD and is associated with more plaques and tangles at autopsy and faster cognitive decline. Results will inform future studies aimed at investigating the cross-species role of Dlgap2 in regulating cognitive decline and highlight the benefit of using genetically diverse mice to prioritize novel candidates.

Keywords: Alzheimer’s; Diversity Outbred; Dlgap2; GWAS; aging; cognition; genetic diversity; resilience; spines; susceptibility; translational.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • African Americans / genetics
  • Age Factors
  • Alzheimer Disease / genetics*
  • Cognitive Dysfunction / genetics*
  • Dementia / genetics*
  • Female
  • Genome-Wide Association Study
  • Humans
  • Male
  • Middle Aged
  • Nerve Tissue Proteins / metabolism*
  • Species Specificity

Substances

  • DLGAP2 protein, human
  • Nerve Tissue Proteins